Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceuticals
Biotech
Teva's $400M Blackstone deal to fund Sanofi-partnered IBD drug
The cash will be spread across four years to fund development of the anti-TL1A antibody duvakitug.
James Waldron
Mar 4, 2026 3:07am
Sanofi points to long-term efficacy of Teva-partnered IBD drug
Feb 17, 2026 8:05am
Fierce Pharma
Teva debuts innovation platform to parry key industry challenges
Nov 19, 2025 8:38am
Atai, Eli Lilly, Novartis & more—Chutes & Ladders
May 17, 2024 8:30am
New CEO will lead Teva at top of new year—Chutes & Ladders
Dec 2, 2022 9:30am
Seagen finally finds new CEO—Chutes & Ladders
Nov 11, 2022 9:30am
